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Letters to the Editor
Hepatic retinopathia: changes in retinal function
To the Editor,
Dr A.K. Eckstein et al. should be congratulated for
publishing a fascinating and intriguing paper entitled,
‘Hepatic retinopathia: changes in retinal function’
which appeared in the June issue of Vision Research
(1997) 37, 1699–1706.
The authors intelligently investigate the decreased
retinal activities (as measured by electroretinograms
(ERGs)) in hepatic encephalopathy (HE). Hepatic
retinopathia is a fine term for evaluation of the retinal
pathology which was coined to reflect the pathological
changes observed by the authors. The ERG abnormali-
ties in hepatic retinopathia corresponded to the severity
of the liver disease.
I would like to make several comments on this
intriguing paper which may be of interest for future
research:
1. The authors noted scleral jaundice in nine out of 11
patients. There were no associated ocular com-
plaints by the patients despite mild changes in the
retinal pigment epithelium (RPE). I may add that in
patients with advanced liver disease, copper can
accumulate in ocular tissues despite normal or ab-
normal levels of ceruloplasmin. Tauber and Steinert
reported that the copper storage might reach to such
high levels that it would produce Pseudo-Kayser-
Fleischer ring (KF) (Tauber & Steinert, 1993). So I
would like to ask whether the copper and cerulo-
plasmin levels were measured or not? In particular
was there any trace deposition of copper in the
cornea?
2. The authors made sure that ERG changes were not
a result of vitamin-A deficiency; but, the inhibitory
effects of GABA and the toxic role of ammonia and
inability of Muller cells to detoxify it was correctly
entertained. Additionally, as I hinted above, there
might be other elements such as defective copper
metabolism which could participate in the abnormal
a-waves, b-waves and oscillatory response. In hu-
mans about 40% of ingested copper is absorbed in
the upper gastrointestinal tract. The 95% of ab-
sorbed copper will be tightly regulated by a delicate
transport mechanism. The 95% of absorbed copper
will be tightly bound to ceruloplasmin by the liver.
Because dietary intake of this heavy metal far ex-
ceeds the trace amount required in enzymes and
proteins, the organisms have evolved precise means
to eliminate the excess. Wilson’s Disease (WD) is
characterized by defective copper export from the
liver into bile and failure to incorporate it into the
ceruloplasmin. So excess copper results in the depo-
sition of copper in the tissues and causes toxicity
such as KF and sunflower cataract (Bull & Cox,
1994). There is no question that in cirrhosis and
advanced obstructive liver diseases copper may in-
crease (Tauber & Steinert, 1993).
3. Although the authors have correctly furnished data
for elevated ammonia, defective glutamine syn-
thetase and Muller cells’ morphological changes, it
is still difficult to attribute all retinal changes exclu-
sively to these findings. We should look for other
variables such as copper and zinc toxicity in the
outer retinal layers. As we know hepatic failure is
associated with a wide variety fndings. In addition
to a list provided by the authors (group 2), copper
and ceruloplasmin changes might be of interest in
advanced cases. Although slit lamp and other ocular
examinations were performed, I wonder if specific
attention was directed to the discovery of faint
Pseudo-Kayser-Fleisher ring in these cases and
whether copper and ceruloplasmin were measured.
It has been shown that WD is caused by mutation in
chromosome 13 (13 q14.3) and is autosomal recessive
(Bull & Cox, 1994). Inspite of this genetic data, I have
found and presented a family of seven children whose
parents were unrelated, two sons were aborted and
three daughters died of WD leaving only one healthy
son. Although the gene is mainly expressed in the liver
and demonstrates a wide range of penetrance, one
might question the autosomal recessive nature of this
disease in light of the family which I have described
above (Kashani, 1977). Untreated WD is fatal but there
are some patients that reach beyond the fifth decade of
life even without treatment. End-stage young WD can
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be cured solely by liver transplantation (Song & Chen,
1992). Therefore while it is obvious that the main
problem(s) reside in the liver, I feel that other genes
may be involved which might be expressed in some
advanced liver diseases. There may be other forms of
Wilson or Pseudo-Wilson disease of which we are not
aware (Kashani, 1977). Even successful treatment of
WD with disappearance of KF ring will not correct
genetic defects of ceruloplasmin deficiency in the body.
The copper metalloenzymes such as amine oxidase,
cytochrome C oxidase, dopamine beta oxidase and
other copper related activities remain defective. Hence
investigation in these areas and their relationship to
ERG activity should be pursued.
Studies by electron microscopy (EM), X-ray energy
spectroscopy (XES), and atomic absorption spec-
trophotometry (AAS) also show that copper is de-
posited next to the endothelium of the cornea and is
associated with a high concentration of sulfur (in form
of metallothioneins) in the area of KF. It appears that
copper is transported by an active process in these cells
(Johnson & Campell, 1982; Van Wassenaer-van Hall,
1997). Other cells with high metabolic activity such as
those in the liver and kidney are also involved (Bull &
Cox, 1994). In addition, a study with single-photon
emission computed tomography (SPECT) indicates
neurological deficits even in treated WD patients
(Oertel, Tatsch, Schwarz, Kraft, Trenkwalder & Scherer
et al., 1992). Therefore, I suggest an ERG study on
Wilson’s Disease patients before and after treatment
and comparison of such data with the author’s findings.
The only report in the literature (up to the best of my
knowledge) which hints to the possible involvement of
retina in copper metabolism is my paper which was
presented in 1977 in England (Kashani, 1977). In my
report of 25 Wilson cases, I noticed that deposition of
copper started in the sequence of superior, inferior,
temporal and nasal side of each cornea with 5 year
observations but did not improve appreciably on D-
penicillinamin with mean follow-up times of one year. I
suggested, for the first time, that copper deposits should
be found on Bruch’s membrane too and this is related
to the activities of the retinal pigment epithelium
(RPE). In my opinion, ultrastructural features and the
copper content of Bruch’s membrane and RPE in
Wilson’s Disease have been neglected and require atten-
tion in future research. The author’s paper may offer a
new approach for research in this complicated area.
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Reply to Dr Kashani
Dear Mr Kashani,
Thank you very much for your interesting comment
on our paper.
You raise the question if there are other causes for
reduced ERG’s in the patients with advanced liver
disease which can cause hepatic encephalopathia. We
directed our attention to ammonia because of its cen-
tral role in the GABA and glutamine:glutamate
metabolism. Other substances may influence it as well,
but to a minor degree (Norenberg, 1996; Butterworth,
1996). The role of copper is very difficult to assess.
In the clinical investigation no patient was found
who displayed a Pseudo-Kayser-Fleischerring. So from
this point of view, there was no hint for severe sec-
ondary copper deposition. The cause of liver cirrhosis
was very heterogeneous in our group, represented
mainly by posthepatic origin of liver damage. Only one
patient suffered from chronic cholestatic liver disease,
.
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known to be associated with severe accumulation of
copper in the tissue. This patient, however, did not
show noticeable differences in comparison to the pa-
tients with the same stage of hepatic encephalopathy as
far as the ERG is concerned.
Measurements of ceruloplasmin and copper were not
performed, because the cause of liver cirrhosis was
ascertained by other means. Methodically the estima-
tion of ceruloplasmin in serum is very problematic, if
conclusions would be drawn to the presence of copper
accumulation. Ceruloplasmin as an acute phase protein
is regulated up by diverse processes. Copper levels
themselves do not correlate with copper accumulation
in the tissue. Local estimations of copper in the eye are
prohibited because of ethical reasons in this experimen-
tal setting.
The next question is, can the copper levels, which
may be increased in patients with chronic liver diseases
cause ERG changes? Hirayama (1990) localized zinc
and copper histochemically in rat ocular tissues. Cop-
per was demonstrated by the rubeanic acid and rhoda-
nine methods. Copper was seen in the corneal
epithelium and endothelium, iris, ciliary body, lens
epithelium, retinal outer nuclear layer, photoreceptor
inner and outer segments, retinal pigment epithelium,
choroid, sclera, and optic nerve. These trace element
seems to play roles as components of some metalloen-
zymes (Hirayama, Dake & Ameniya, 1992) and may
have other functions, still unknown.
Can pathologically high levels cause ERG changes?
ERG changes due to copper are known from ocular
injuries with foreign bodies or from experimental in-
duced metallosis (Schmidt, 1987). Moschos, Panagakis,
Palimeris and Velissaropoulos (1977) studied the elec-
troretinographic alterations and the histological lesions
after the introduction of foreign (iron and copper)
bodies into the vitreous body of eyes of rabbits. The
ERG alterations depend on the kind of intraocular
foreign body and on the size and time it remained in
the eye. Alterations due to copper were characterised
either by a parallel diminution of the a and b wave of
the ERG, or by an increase of the a wave while the b
wave became flat. In histological studies, it was found
that the copper causes a violent inflammatory reaction
and was deposited extracellularly.
Although there are no data, it is safe to assume that
in metallosis, induced by foreign bodies in the eye, toxic
ocular copper levels are much higher than the levels
measured in ocular tissues of patients with liver disease.
Therefore no direct conclusions can be drawn from
investigations with intraocular foreign bodies.
The only sensible way to answer this interesting
question concerning the role of copper metabolism for
retinal function would be either an animal experiment
or the investigation of different stages of hepatic en-
cephalopathy in a homogenous population of patients
with verified copper storage disease.
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